KFC
ZBH icon

Klingenstein Fields & Co’s Zimmer Biomet ZBH Stock Holding History

Klingenstein Fields & Co’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,379
Closed -$282K – 230
2017
Q1 		$282K Buy
+2,379
New +$270K 0.01% 188
2014
Q1 		– Sell
-3,966
Closed -$359K – 293
2013
Q4 		$359K Sell
3,966
-206
-5% -$17.8K 0.01% 242
2013
Q3 		$333K Sell
4,172
-3,413
-45% -$269K 0.01% 242
2013
Q2 		$552K Buy
+7,585
New +$567K 0.02% 202

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Klingenstein Fields & Co's ZBH Position: Q2 2017 in Review

Klingenstein Fields & Co sold out of Zimmer Biomet (ZBH) in Q2 2017, closing a stake of 2,379 shares — an estimated $282K sold.

Klingenstein Fields & Co first reported a position in ZBH in Q2 2013 and held it in 4 quarters. The position peaked at $552K in Q2 2013. 819 funds tracked by Wall St. Rank hold ZBH as of Q2 2017.

  • Klingenstein Fields & Co reported no remaining Zimmer Biomet position as of Q2 2017 after selling out during the quarter.
  • Klingenstein Fields & Co sold 2,379 Zimmer Biomet shares in Q2 2017, an estimated $282K.
  • Klingenstein Fields & Co first reported a position in Zimmer Biomet in Q2 2013 and held it in 4 quarters.
  • Klingenstein Fields & Co's Zimmer Biomet position peaked at $552K in Q2 2013.
  • 819 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2017.

Based on Klingenstein Fields & Co's 13F filing for Q2 2017, filed 27 Jul 2017.